600572.SH
康恩贝
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 4.21
−2.55%Margins
Gross margin
53.9%
EBITDA margin
15.3%
EBIT margin
10.4%
Net margin
7.2%
FCF margin
13.1%
6.7%
Return on equity
4.7%
Return on assets
9.5%
Return on invested capital
0.66x
Asset turnover
CNY 1.0B
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026